troglitazone has been researched along with Muscle Contraction in 2 studies
Troglitazone: A chroman and thiazolidinedione derivative that acts as a PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPAR) agonist. It was formerly used in the treatment of TYPE 2 DIABETES MELLITUS, but has been withdrawn due to hepatotoxicity.
Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iida, KT | 1 |
Kawakami, Y | 1 |
Suzuki, M | 1 |
Shimano, H | 1 |
Toyoshima, H | 1 |
Sone, H | 1 |
Shimada, K | 1 |
Iwama, Y | 1 |
Watanabe, Y | 1 |
Mokuno, H | 1 |
Kamata, K | 1 |
Yamada, N | 1 |
Song, J | 1 |
Walsh, MF | 1 |
Igwe, R | 1 |
Ram, JL | 1 |
Barazi, M | 1 |
Dominguez, LJ | 1 |
Sowers, JR | 1 |
2 other studies available for troglitazone and Muscle Contraction
Article | Year |
---|---|
Effect of thiazolidinediones and metformin on LDL oxidation and aortic endothelium relaxation in diabetic GK rats.
Topics: Acetylcholine; Animals; Aorta, Thoracic; Arteriosclerosis; Cholesterol, LDL; Chromans; Diabetes Mell | 2003 |
Troglitazone reduces contraction by inhibition of vascular smooth muscle cell Ca2+ currents and not endothelial nitric oxide production.
Topics: Analysis of Variance; Animals; Arteries; Calcium Channels; Chromans; Dose-Response Relationship, Dru | 1997 |